Description

Research-grade Thymosin Alpha-1 for laboratories examining immune signaling and cytokine-response pathways.

Brava Longevity’s Thymosin Alpha-1 is selected for researchers investigating immune signaling, cytokine dynamics, and pathway-level modulation in controlled models. Strength options support both pilot design and longer study windows with fewer reconstitutions. Strictly RUO for qualified research environments.

Best For: Immune; Resilience

Category: Immune

Example Research Protocol Ranges: Example Research Protocol Range: 0.5–1.5 mg per administration; 2–3x weekly; study windows commonly 4–12 weeks (model-dependent).

For Research Use Only (RUO). Not for human or veterinary use. Not a drug. Not intended to diagnose, treat, cure, or prevent any disease.